Biosenta Inc. (CSE:ZRO)
Canada · Delayed Price · Currency is CAD 0.0750
+0.0200 (36.36%)
Aug 7, 2026, 5:32 PM EST
Biosenta Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | -2.39 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 |
Depreciation & Amortization | 0 | 0 | 0 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 4.79 | - | - |
Stock-Based Compensation | 0.27 | 0.32 | 0.06 | 0.17 | 0.11 | 0.89 |
Other Operating Activities | 0.97 | 1.1 | 1.11 | 0 | 0.03 | 0.01 |
Change in Accounts Receivable | 0.04 | 0.04 | -0.03 | -0.01 | -0.14 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | -0.05 |
Change in Accounts Payable | 0.69 | 0.58 | 0.28 | 0.78 | 0.92 | 0.56 |
Change in Other Net Operating Assets | - | 0.01 | 0.02 | 0.02 | 0.03 | -0.04 |
Operating Cash Flow | -0.43 | -0.46 | -0.78 | -0.55 | -0.5 | -0.67 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Capital Expenditures | -0 | -0.03 | - | -0.02 | - | - |
Investing Cash Flow | -0 | -0.03 | - | -0.02 | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Short-Term Debt Issued | - | 0.5 | - | 0.54 | 0.48 | 0.39 |
Long-Term Debt Issued | - | - | - | - | - | 0.02 |
Total Debt Issued | 0.43 | 0.5 | - | 0.54 | 0.48 | 0.41 |
Short-Term Debt Repaid | - | - | -0.3 | - | -0.06 | - |
Total Debt Repaid | -0 | - | -0.3 | - | -0.06 | - |
Net Debt Issued (Repaid) | 0.43 | 0.5 | -0.3 | 0.54 | 0.42 | 0.41 |
Issuance of Common Stock | - | - | 0.74 | - | - | 0.33 |
Other Financing Activities | - | - | 0.35 | - | - | - |
Financing Cash Flow | 0.43 | 0.5 | 0.78 | 0.54 | 0.42 | 0.74 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Cash Flow | 0.01 | 0.02 | 0 | -0.02 | -0.08 | 0.07 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -0.43 | -0.48 | -0.78 | -0.57 | -0.5 | -0.67 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -10994.43% | -39738.81% | -56515.45% | -54351.92% | -43825.63% | -399.92% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.02 | -0.02 | -0.04 |
Levered Free Cash Flow | -0.07 | -0.03 | -1.25 | 0.12 | -0.96 | 0.01 |
Unlevered Free Cash Flow | 0.54 | 0.67 | -0.54 | 0.16 | -0.82 | 0.02 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Change in Working Capital | 0.73 | 0.63 | 0.28 | 0.79 | 0.81 | 0.47 |